1,060 results on '"Hugosson, Jonas"'
Search Results
52. Thromboembolic Complications in 3,544 Patients Undergoing Radical Prostatectomy with or without Lymph Node Dissection
53. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
54. Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only
55. Rehospitalization after Radical Prostatectomy in a Nationwide, Population Based Study
56. The efficacy of prostate‐specific antigen screening: Impact of key components in the ERSPC and PLCO trials
57. Social constraints and psychological well‐being after prostate cancer: A follow‐up at 12 and 24 months after surgery
58. Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening : population based cohort study
59. Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer
60. Surgeon volume and patient-reported urinary incontinence after radical prostatectomy. Population-based register study in Sweden
61. Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial
62. Prostate cancer: ESMO Consensus Conference Guidelines 2012
63. Risk of severe late toxicity after radiotherapy following radical prostatectomy : a nationwide study
64. Surgeon volume and patient-reported urinary incontinence after radical prostatectomy : Population-based register study in Sweden
65. Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials
66. Risk of severe late toxicity after radiotherapy following radical prostatectomy – a nationwide study
67. Inherited Genetic Variant Predisposes to Aggressive but Not Indolent Prostate Cancer
68. False-positive screening results in the European randomized study of screening for prostate cancer
69. Prediction of prostate cancer in unscreened men: External validation of a risk calculator
70. The excess burden of side-effects from treatment in men allocated to screening for prostate cancer. The Göteborg randomised population-based prostate cancer screening trial
71. Lymph swelling after radical prostatectomy and pelvic lymph node dissection
72. Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium
73. Evaluating the Prostate Cancer Prevention Trial High Grade prostate cancer risk calculator in 10 international biopsy cohorts: results from the prostate biopsy collaborative group
74. BASELINE PSA BEFORE AGE 60 AS A PREDICTOR OF IMPORTANT PROSTATE CANCER DIAGNOSIS AND PROSTATE CANCER-SPECIFIC MORTALITY IN THE INTERVENTION ARM OF THE PROSTATE, LUNG, COLORECTAL AND OVARIAN TRIAL: MP39-11
75. ESTIMATING THE HARMS AND BENEFITS OF PROSTATE CANCER SCREENING: COMPARING COMMON CLINICAL PRACTICE TO RECOMMENDED GOOD PRACTICE: PD09-04
76. CORRELATION BETWEEN STAGE SHIFT AND DIFFERENCES IN MORTALITY BETWEEN THE TWO STUDY ARMS OF THE ERSPC.: PD09-01
77. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial
78. Lead-time in the European Randomised Study of Screening for Prostate Cancer
79. Outcome of Primary Versus Deferred Radical Prostatectomy in the National Prostate Cancer Register of Sweden Follow-Up Study
80. Prostate Specific Antigen Velocity Does Not Aid Prostate Cancer Detection in Men With Prior Negative Biopsy
81. Post-Radical Prostatectomy Inguinal Hernia: A Simple Surgical Intervention can Substantially Reduce the Incidence—Results From a Prospective Randomized Trial
82. Prostate Cancer Mortality in Areas With High and Low Prostate Cancer Incidence
83. Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database
84. Prostate-Specific Antigen Velocity for Early Detection of Prostate Cancer: Result from a Large, Representative, Population-based Cohort
85. Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)
86. MP60-10 SHOULD SCREENING FOR PROSTATE CANCER START BEFORE THE AGE OF 55?
87. Outcomes of Men with Screen-Detected Prostate Cancer Eligible for Active Surveillance Who Were Managed Expectantly
88. Prostate Cancer Diffusion‐Weighted Magnetic Resonance Imaging : Does the Choice of Diffusion‐Weighting Level Matter?
89. PD13-04 PROSTATE CANCER SPECIFIC MORTALITY IN THE ERSPC TRIAL: WHAT IS THE ROLE OF SCREENING RESULT AND ADHERENCE
90. The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer
91. sj-pdf-1-msc-10.1177_0969141321989738 - Supplemental material for Impact of cancer screening on metastasis: A prostate cancer case study
92. Prostate cancer grading, time to go back to the future.
93. Impact of cancer screening on metastasis : A prostate cancer case study
94. Association of surgeon and hospital volume with short-term outcomes after robot-assisted radical prostatectomy : Nationwide, population-based study
95. Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group
96. Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group
97. Surveillance and Deferred Treatment for Localized Prostate Cancer. Population Based Study in the National Prostate Cancer Register of Sweden
98. Rehospitalization after Radical Prostatectomy in a Nationwide, Population Based Study
99. RE: Prostate-Specific Antigen Screening Trials and Prostate Cancer Deaths: The Androgen Deprivation Connection
100. INFLUENCE OF BLOOD LEVELS OF PROSTATE-SPECIFIC ANTIGEN AT AGE 60 ON THE BENEFITS AND HARMS OF PROSTATE CANCER SCREENING: MP69-11
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.